{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:01:25Z","timestamp":1789786885327,"version":"4.0.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02544-w","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:07:44Z","timestamp":1789780064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alzheimer\u2019s disease biomarkers in relation to non-cognitive domains within the intrinsic capacity framework: a narrative review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-3464","authenticated-orcid":false,"given":"Xiaoxia","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipe","family":"de Souto Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"2544_CR1","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","volume":"387","author":"JR Beard","year":"2016","unstructured":"Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387:2145\u201354.","journal-title":"Lancet"},{"key":"2544_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.14336\/AD.2021.0818","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Ma L. Intrinsic capacity in older adults: recent advances. Aging Dis. 2022;13:353\u20139.","journal-title":"Aging Dis"},{"key":"2544_CR3","doi-asserted-by":"publisher","first-page":"e259792","DOI":"10.1001\/jamanetworkopen.2025.9792","volume":"8","author":"M Chen","year":"2025","unstructured":"Chen M, Hanewald K, Si Y, Gu Y, Beard JR. Intrinsic capacity across 15 countries in the survey of health, aging, and retirement in Europe. JAMA Netw Open. 2025;8:e259792.","journal-title":"JAMA Netw Open"},{"key":"2544_CR4","first-page":"698","volume":"78","author":"CL Campbell","year":"2023","unstructured":"Campbell CL, Cadar D, McMunn A, Zaninotto P. Operationalization of intrinsic capacity in older people and its association with subsequent disability, hospital admission and mortality: results from the English longitudinal study of ageing. The Journals of Gerontology: Series A. 2023;78:698\u2013703.","journal-title":"The Journals of Gerontology: Series A"},{"key":"2544_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/gerona\/glab279","volume":"77","author":"E Stolz","year":"2022","unstructured":"Stolz E, Mayerl H, Freidl W, Roller-Wirnsberger R, Gill TM. Intrinsic capacity predicts negative health outcomes in older adults. J Gerontol A Biol Sci Med Sci. 2022;77:101\u20135.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf196","volume":"80","author":"MB Beyene","year":"2025","unstructured":"Beyene MB, Visvanathan R, Alemu R, Benyamin B, Bhattacharjee R, Beyene HB, et al. A genome-wide association study identified 10 novel genomic loci associated with intrinsic capacity. J Gerontol A Biol Sci Med Sci. 2025;80:glaf196.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-05709-y","volume":"25","author":"S Ahmadi","year":"2025","unstructured":"Ahmadi S, Afshar PF, Malakouti K, Azadbakht M. The relationship between intrinsic capacity and functional ability in older adults. BMC Geriatr. 2025;25:57.","journal-title":"BMC Geriatr"},{"key":"2544_CR8","doi-asserted-by":"publisher","unstructured":"Numbers K, Samtani S, Hanewald K, Cheung J, Sachdev PS, Brodaty H. Intrinsic capacity predictors of dementia and mortality in the sydney memory and ageing study. Int J Geriatr Psychiatry. 2025;40(10):e70156. https:\/\/doi.org\/10.1002\/gps.70156","DOI":"10.1002\/gps.70156"},{"key":"2544_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11040450","author":"J Zhou","year":"2023","unstructured":"Zhou J, Chang H, Leng M, Wang Z. Intrinsic capacity to predict future adverse health outcomes in older adults: a scoping review. Healthcare (Basel). 2023. https:\/\/doi.org\/10.3390\/healthcare11040450.","journal-title":"Healthcare (Basel)"},{"key":"2544_CR10","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s & dementia\u202f: the journal of the Alzheimer\u2019s Association. 2024;20:5143\u201369.","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association"},{"key":"2544_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/ane.13628","volume":"146","author":"H Zetterberg","year":"2022","unstructured":"Zetterberg H, Schott JM. Blood biomarkers for Alzheimer\u2019s disease and related disorders. Acta Neurol Scand. 2022;146:51\u20135.","journal-title":"Acta Neurol Scand"},{"key":"2544_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biom14010093","author":"G Garcia-Escobar","year":"2024","unstructured":"Garcia-Escobar G, Manero RM, Fern\u00e1ndez-Lebrero A, Ois A, Navalpotro-G\u00f3mez I, Puente-Periz V, et al. Blood biomarkers of Alzheimer\u2019s disease and cognition: a literature review. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14010093.","journal-title":"Biomolecules"},{"key":"2544_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034997","volume":"102","author":"G Rao","year":"2023","unstructured":"Rao G, Gao H, Wang X, Zhang J, Ye M, Rao L. MRI measurements of brain hippocampus volume in relation to mild cognitive impairment and Alzheimer disease: a systematic review and meta-analysis. Medicine (Baltimore). 2023;102:e34997.","journal-title":"Medicine (Baltimore)"},{"key":"2544_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102046","volume":"91","author":"A Gaur","year":"2023","unstructured":"Gaur A, Rivet L, Mah E, Bawa KK, Gallagher D, Herrmann N, et al. Novel fluid biomarkers for mild cognitive impairment: a systematic review and meta-analysis. Ageing Res Rev. 2023;91:102046.","journal-title":"Ageing Res Rev"},{"key":"2544_CR15","doi-asserted-by":"publisher","first-page":"e1866","DOI":"10.1212\/WNL.0000000000201072","volume":"99","author":"A Rostamzadeh","year":"2022","unstructured":"Rostamzadeh A, Bohr L, Wagner M, Baethge C, Jessen F. Progression of subjective cognitive decline to MCI or dementia in relation to biomarkers for Alzheimer disease: a meta-analysis. Neurology. 2022;99:e1866\u201374.","journal-title":"Neurology"},{"key":"2544_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13195-024-01455-2","volume":"16","author":"Z Husz\u00e1r","year":"2024","unstructured":"Husz\u00e1r Z, Engh MA, Pavlekovics M, Sato T, Steenkamp Y, Hanseeuw B, et al. Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis. Alzheimer\u2019s research & therapy. 2024;16:81.","journal-title":"Alzheimer's research & therapy"},{"key":"2544_CR17","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.neuron.2012.03.004","volume":"73","author":"J Zhou","year":"2012","unstructured":"Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron. 2012;73:1216\u201327.","journal-title":"Neuron"},{"key":"2544_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-142940","volume":"46","author":"NJ Donovan","year":"2015","unstructured":"Donovan NJ, Hsu DC, Dagley AS, Schultz AP, Amariglio RE, Mormino EC, et al. Depressive symptoms and biomarkers of Alzheimer\u2019s disease in cognitively normal older adults. J Alzheimers Dis. 2015;46:63\u201373.","journal-title":"J Alzheimers Dis"},{"key":"2544_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00415-024-12800-8","volume":"272","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Zhao G, Zhao Y. Dysregulation of energy metabolism in Alzheimer\u2019s disease. J Neurol. 2024;272:2.","journal-title":"J Neurol"},{"key":"2544_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 2022;21:66\u201377.","journal-title":"Lancet Neurol"},{"key":"2544_CR21","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. Available from: https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale. Accessed 17 Sep 2026."},{"key":"2544_CR22","doi-asserted-by":"publisher","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI manual for evidence synthesis. JBI; 2020. https:\/\/doi.org\/10.46658\/JBIMES-20-08.","DOI":"10.46658\/JBIMES-20-08"},{"key":"2544_CR23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/gps.4409","volume":"31","author":"F Yasuno","year":"2016","unstructured":"Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, et al. High amyloid-\u03b2 deposition related to depressive symptoms in older individuals with normal cognition: a pilot study. Int J Geriatr Psychiatry. 2016;31:920\u20138.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2544_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.18314","volume":"5","author":"KA Duchowny","year":"2022","unstructured":"Duchowny KA, Ackley SF, Brenowitz WD, Wang J, Zimmerman SC, Caunca MR, et al. Associations between handgrip strength and dementia risk, cognition, and neuroimaging outcomes in the UK Biobank Cohort Study. JAMA Netw Open. 2022;5:e2218314.","journal-title":"JAMA Netw Open"},{"key":"2544_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jad.2024.09.063","volume":"368","author":"K Zhang","year":"2025","unstructured":"Zhang K, Cheng M, Yang P, Hu Y, Liang X, Li M, et al. Association between serum neurofilament light chains and depression: a cross-sectional study based on NHANES 2013\u20132014 database. J Affect Disord. 2025;368:591\u20138.","journal-title":"J Affect Disord"},{"key":"2544_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jnnp-2022-329726","volume":"94","author":"JJ van 't Hooft","year":"2023","unstructured":"van \u2019t Hooft JJ, Pelkmans W, Tomassen J, Smits C, Legdeur N, den Braber A, et al. Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups. J Neurol Neurosurg Psychiatry. 2023;94:314\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2544_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jagp.2016.04.004","volume":"24","author":"GM Babulal","year":"2016","unstructured":"Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TLS, et al. Mood changes in cognitively normal older adults are linked to Alzheimer disease biomarker levels. The American journal of geriatric psychiatry\u202f: official journal of the American Association for Geriatric Psychiatry. 2016;24:1095\u2013104.","journal-title":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry"},{"key":"2544_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/jamaoto.2019.1610","volume":"145","author":"NM Armstrong","year":"2019","unstructured":"Armstrong NM, An Y, Doshi J, Erus G, Ferrucci L, Davatzikos C, et al. Association of midlife hearing impairment with late-life temporal lobe volume loss. JAMA Otolaryngol Head Neck Surg. 2019;145:794\u2013802.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2544_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjfa.2025.100064","volume":"14","author":"KV Giudici","year":"2025","unstructured":"Giudici KV, de Souto Barreto P, Cantet C, Zetterberg H, Blennow K, Vellas B. Associations between intrinsic capacity, plasma p-tau181 and cognitive function over a 5-year follow-up among community-dwelling older adults: a secondary analysis of the MAPT study. J Frailty Aging. 2025;14:100064.","journal-title":"J Frailty Aging"},{"key":"2544_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.108191","volume":"193","author":"LC de Assun\u00e7\u00e3o Cortez Corr\u00eaa","year":"2025","unstructured":"de Assun\u00e7\u00e3o Cortez Corr\u00eaa LC, Raffin J, Vellas B, Guerra RO, de Souto Barreto P. Sex-specific associations of neurodegeneration and inflammatory biomarkers with intrinsic capacity in older adults: findings from the 4-year longitudinal Multidomain Alzheimer\u2019s Prevention Trial (MAPT). Maturitas. 2025;193:108191.","journal-title":"Maturitas"},{"key":"2544_CR31","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s11682-020-00435-y","volume":"15","author":"KJ Sullivan","year":"2021","unstructured":"Sullivan KJ, Ranadive R, Su D, Neyland BR, Hughes TM, Hugenschmidt CE, et al. Imaging-based indices of neuropathology and gait speed decline in older adults: the atherosclerosis risk in communities study. Brain Imaging Behav. 2021;15:2387\u201396.","journal-title":"Brain Imaging Behav"},{"key":"2544_CR32","first-page":"716","volume":"72","author":"Q Tian","year":"2017","unstructured":"Tian Q, Resnick SM, Bilgel M, Wong DF, Ferrucci L, Studenski SA. \u03b2-Amyloid burden predicts lower extremity performance decline in cognitively unimpaired older adults. J Gerontol A Biol Sci Med Sci. 2017;72:716\u201323.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR33","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/gerona\/glaa284","volume":"76","author":"L He","year":"2021","unstructured":"He L, de Souto Barreto P, Giudici KV, Aggarwal G, Nguyen AD, Morley JE, et al. Cross-sectional and longitudinal associations between plasma neurodegenerative biomarkers and physical performance among community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2021;76:1874\u201381.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.14283\/jfa.2022.17","volume":"11","author":"ME Jacob","year":"2022","unstructured":"Jacob ME, O\u2019Donnell A, Samra J, Gonzales MM, Satizabal C, Pase MP, et al. Grip strength, gait speed and plasma markers of neurodegeneration in asymptomatic middle-aged and older adults. J Frailty Aging. 2022;11:291\u20138.","journal-title":"J Frailty Aging"},{"key":"2544_CR35","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/alz.12537","volume":"18","author":"T Skillb\u00e4ck","year":"2022","unstructured":"Skillb\u00e4ck T, Blennow K, Zetterberg H, Skoog J, Ryd\u00e9n L, Wetterberg H, et al. Slowing gait speed precedes cognitive decline by several years. Alzheimer\u2019s & dementia\u202f: the journal of the Alzheimer\u2019s Association. 2022;18:1667\u201376.","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association"},{"key":"2544_CR36","doi-asserted-by":"publisher","unstructured":"Nadkarni AN, Mukamal KJ, Zhu X, Siscovick D, Brach JS, Jacob M, et al. Associations of neurological biomarkers in serum with gait measures: the cardiovascular health study. J Gerontol A Biol Sci Med Sci. 2024;79(5):glae043. https:\/\/doi.org\/10.1093\/gerona\/glae043","DOI":"10.1093\/gerona\/glae043"},{"key":"2544_CR37","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.3233\/JAD-180848","volume":"71","author":"E Dao","year":"2019","unstructured":"Dao E, Hsiung GR, Sossi V, Tam R, Shahinfard E, Nicklin E, et al. Cerebral amyloid-\u03b2 deposition is associated with impaired gait speed and lower extremity function. Journal of Alzheimer\u2019s disease\u202f: JAD. 2019;71:S41\u20139.","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"2544_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2016.3474","volume":"74","author":"NK Nadkarni","year":"2017","unstructured":"Nadkarni NK, Perera S, Snitz BE, Mathis CA, Price J, Williamson JD, et al. Association of brain amyloid-\u03b2 with slow gait in elderly individuals without dementia: influence of cognition and apolipoprotein E \u03b54 genotype. JAMA Neurol. 2017;74:82\u201390.","journal-title":"JAMA Neurol"},{"key":"2544_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1212\/WNL.0000000000002235","volume":"86","author":"N Del Campo","year":"2016","unstructured":"Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, et al. Relationship of regional brain \u03b2-amyloid to gait speed. Neurology. 2016;86:36\u201343.","journal-title":"Neurology"},{"key":"2544_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/13872877251359638","volume":"107","author":"NK Nadkarni","year":"2025","unstructured":"Nadkarni NK, Perera S, Snitz BE, Lopresti BJ, Gogniat MA, Villemagne VL, et al. Brain amyloid-\u03b2 deposition, severity of subjective cognitive decline and gait speed in cognitively unimpaired oldest-old. Journal of Alzheimer\u2019s disease\u202f: JAD. 2025;107:39\u201345.","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"2544_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1101306","volume":"15","author":"GG Tangen","year":"2023","unstructured":"Tangen GG, Sverdrup K, Taraldsen K, Persson K, Engedal K, Bekkhus-Wetterberg P, et al. Mobility and associations with levels of cerebrospinal fluid amyloid \u03b2 and tau in a memory clinic cohort. Front Aging Neurosci. 2023;15:1101306.","journal-title":"Front Aging Neurosci"},{"key":"2544_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf110","author":"AC Thompson","year":"2025","unstructured":"Thompson AC, Leng X, Miller ME, Register TC, Laurienti PJ, Mielke MM, et al. Relationship of Alzheimer\u2019s disease and related dementias plasma biomarkers with mobility in cognitively unimpaired older adults. J Gerontol A Biol Sci Med Sci. 2025. https:\/\/doi.org\/10.1093\/gerona\/glaf110.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-02055-0","author":"S Bekena","year":"2025","unstructured":"Bekena S, Singh RK, Zhu Y, Carr DB, Babulal GM. Sensorimotor function as an early marker of cognitive decline and Alzheimer\u2019s biomarker burden. GeroScience. 2025. https:\/\/doi.org\/10.1007\/s11357-025-02055-0.","journal-title":"GeroScience"},{"key":"2544_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112975","volume":"212","author":"PH Chen","year":"2025","unstructured":"Chen PH, Lin SI, Liao YY, Hu GC, Cheng FY. Plasma Alzheimer\u2019s biomarkers and physical functions in aging adults with and without motoric cognitive risk syndrome. Exp Gerontol. 2025;212:112975.","journal-title":"Exp Gerontol"},{"key":"2544_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exger.2019.01.004","volume":"118","author":"S Lee","year":"2019","unstructured":"Lee S, Kim EY, Shin C. Longitudinal association between brain volume change and gait speed in a general population. Exp Gerontol. 2019;118:26\u201330.","journal-title":"Exp Gerontol"},{"key":"2544_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13195-020-00697-0","volume":"12","author":"L He","year":"2020","unstructured":"He L, de Souto BP, Aggarwal G, Nguyen AD, Morley JE, Li Y, et al. Plasma A\u03b2 and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults. Alzheimer\u2019s research & therapy. 2020;12:128.","journal-title":"Alzheimer\u2019s research & therapy"},{"key":"2544_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s13760-025-02759-2","volume":"125","author":"R Qaisar","year":"2025","unstructured":"Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F. Associations of plasma neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer\u2019s diseases. Acta Neurol Belg. 2025;125:691\u20138.","journal-title":"Acta Neurol Belg"},{"key":"2544_CR48","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s40520-023-02521-9","volume":"35","author":"A Ladang","year":"2023","unstructured":"Ladang A, Kovacs S, Lengel\u00e9 L, Locquet M, Beaudart C, Reginster JY, et al. Neurofilament-light chains (NF-L), a biomarker of neuronal damage, is increased in patients with severe sarcopenia: results of the SarcoPhAge study. Aging Clin Exp Res. 2023;35:2029\u201337.","journal-title":"Aging Clin Exp Res"},{"key":"2544_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.939155","volume":"14","author":"M Kartau","year":"2023","unstructured":"Kartau M, Melkas S, Kartau J, Arola A, Laakso H, Pitk\u00e4nen J, et al. Neurofilament light level correlates with brain atrophy, and cognitive and motor performance. Front Aging Neurosci. 2023;14:939155.","journal-title":"Front Aging Neurosci"},{"key":"2544_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612751","author":"X Capo","year":"2023","unstructured":"Capo X, Galmes-Panades AM, Navas-Enamorado C, Ortega-Moral A, Mar\u00edn S, Cascante M, et al. Circulating neurofilament light chain levels increase with age and are associated with worse physical function and body composition in men but not in women. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241612751.","journal-title":"Int J Mol Sci"},{"key":"2544_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.13123","volume":"2","author":"LJH Rasmussen","year":"2019","unstructured":"Rasmussen LJH, Caspi A, Ambler A, Broadbent JM, Cohen HJ, d\u2019Arbeloff T, et al. Association of neurocognitive and physical function with gait speed in midlife. JAMA Netw Open. 2019;2:e1913123.","journal-title":"JAMA Netw Open"},{"key":"2544_CR52","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209307","volume":"102","author":"L Grasset","year":"2024","unstructured":"Grasset L, Bouteloup V, Cacciamani F, Pellegrin I, Planche V, Ch\u00eane G, et al. Associations between blood-based biomarkers and cognitive and functional trajectories among participants of the MEMENTO cohort. Neurology. 2024;102:e209307.","journal-title":"Neurology"},{"key":"2544_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/gerona\/glac169","volume":"78","author":"SE O'Bryant","year":"2023","unstructured":"O\u2019Bryant SE, Petersen M, Hall JR, Large S, Johnson LA. Plasma biomarkers of Alzheimer\u2019s disease are associated with physical functioning outcomes among cognitively normal adults in the multiethnic HABS-HD cohort. J Gerontol A Biol Sci Med Sci. 2023;78:9\u201315.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14322","volume":"21","author":"G Knell","year":"2025","unstructured":"Knell G, Hall JR, Large S, Abdullah L, Petersen M, Johnson LA, et al. Alzheimer\u2019s disease plasma biomarkers and physical functioning in a diverse sample of adults. Alzheimer\u2019s & dementia\u202f: the journal of the Alzheimer\u2019s Association. 2025;21:e14322.","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association"},{"key":"2544_CR55","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/geronb\/gbaa152","volume":"76","author":"N Legdeur","year":"2021","unstructured":"Legdeur N, Badissi M, Yaqub M, Beker N, Sudre CH, Ten Kate M, et al. What determines cognitive functioning in the oldest-old? The EMIF-AD 90+ study. J Gerontol B Psychol Sci Soc Sci. 2021;76:1499\u2013511.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"2544_CR56","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.clnu.2024.05.024","volume":"43","author":"H Chu","year":"2024","unstructured":"Chu H, Huang C, Guan Y, Xie F, Chen M, Guo Q. The associations between nutritional status and physical frailty and Alzheimer\u2019s disease plasma biomarkers in older cognitively unimpaired adults with positive of amyloid-\u03b2 PET. Clin Nutr. 2024;43:1647\u201356.","journal-title":"Clin Nutr"},{"key":"2544_CR57","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/gerona\/glaa143","volume":"76","author":"MH Nilsson","year":"2021","unstructured":"Nilsson MH, Tangen GG, Palmqvist S, van Westen D, Mattsson-Carlgren N, Stomrud E, et al. The effects of tau, amyloid, and white matter lesions on mobility, dual tasking, and balance in older people. J Gerontol A Biol Sci Med Sci. 2021;76:683\u201391.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2025.100715","volume":"6","author":"AM Ornago","year":"2025","unstructured":"Ornago AM, Pinardi E, Grande G, Valletta M, Calder\u00f3n-Larra\u00f1aga A, Andersson S, et al. Blood biomarkers of Alzheimer\u2019s disease and 12-year muscle strength trajectories in community-dwelling older adults: a cohort study. Lancet Healthy Longev. 2025;6:100715.","journal-title":"Lancet Healthy Longev"},{"key":"2544_CR59","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/gerona\/glw195","volume":"72","author":"BP de Souto","year":"2017","unstructured":"de Souto BP, Cesari M, Rolland Y, Salabert AS, Payoux P, Andrieu S, et al. Cross-sectional and prospective associations between \u03b2-amyloid in the brain and chair rise performance in nondementia older adults with spontaneous memory complaints. J Gerontol A Biol Sci Med Sci. 2017;72:278\u201383.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf268","author":"JC Michaelian","year":"2026","unstructured":"Michaelian JC, Trares K, Stevenson-Hoare J, Holleczek B, Sch\u00f6ttker B, Brenner H. Frailty, grip strength, blood-based biomarkers of neuropathology, and incident dementia: a 17-year longitudinal population study. J Gerontol A Biol Sci Med Sci. 2026. https:\/\/doi.org\/10.1093\/gerona\/glaf268.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814079","author":"SN Sampatakakis","year":"2023","unstructured":"Sampatakakis SN, Mamalaki E, Ntanasi E, Kalligerou F, Liampas I, Yannakoulia M, et al. Objective physical function in the Alzheimer\u2019s disease continuum: association with cerebrospinal fluid biomarkers in the ALBION study. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241814079.","journal-title":"Int J Mol Sci"},{"key":"2544_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-02007-8","author":"GY Yitbarek","year":"2025","unstructured":"Yitbarek GY, Alty J, Roccati E, Lawler K, Goldberg LR. Association of tongue, handgrip, and pinch strength with blood-based phosphorylated-tau 181 in cognitively healthy older adults. GeroScience. 2025. https:\/\/doi.org\/10.1007\/s11357-025-02007-8.","journal-title":"GeroScience"},{"key":"2544_CR63","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12877-021-02411-7","volume":"21","author":"Q Dercon","year":"2021","unstructured":"Dercon Q, Nicholas JM, James SN, Schott JM, Richards M. Grip strength from midlife as an indicator of later-life brain health and cognition: evidence from a British birth cohort. BMC Geriatr. 2021;21:475.","journal-title":"BMC Geriatr"},{"key":"2544_CR64","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jcsm.12979","volume":"13","author":"J Pratt","year":"2022","unstructured":"Pratt J, De Vito G, Segurado R, Pessanha L, Dolan J, Narici M, et al. Plasma neurofilament light levels associate with muscle mass and strength in middle-aged and older adults: findings from GenoFit. J Cachexia Sarcopenia Muscle. 2022;13:1811\u201320.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2544_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-084766","volume":"15","author":"D Dilixiati","year":"2025","unstructured":"Dilixiati D, Kadier K, Qiao B, Zhang W, Nuerdebieke D, Zebibula A, et al. Association between serum neurofilament light chain levels and grip strength among US adults: a cross-sectional study using National Health and Nutrition Examination Survey data from 2013 to 2014. BMJ Open. 2025;15:e084766.","journal-title":"BMJ Open"},{"key":"2544_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-02057-y","author":"AIB Posis","year":"2025","unstructured":"Posis AIB, Colbeth HL, Deshpande MS, George KM, Rizvi B, Alam RB, et al. Is grip strength a marker for cognitive function, neurodegeneration, and resilience? GeroScience. 2025. https:\/\/doi.org\/10.1007\/s11357-025-02057-y.","journal-title":"GeroScience"},{"key":"2544_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/nu11051161","author":"AS Doorduijn","year":"2019","unstructured":"Doorduijn AS, Visser M, van de Rest O, Kester MI, de Leeuw FA, Boesveldt S, et al. Associations of AD biomarkers and cognitive performance with nutritional status: the NUDAD project. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11051161.","journal-title":"Nutrients"},{"key":"2544_CR68","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jpsychires.2012.12.008","volume":"47","author":"N Direk","year":"2013","unstructured":"Direk N, Schrijvers EM, de Bruijn RF, Mirza S, Hofman A, Ikram MA, et al. Plasma amyloid \u03b2, depression, and dementia in community-dwelling elderly. J Psychiatr Res. 2013;47:479\u201385.","journal-title":"J Psychiatr Res"},{"key":"2544_CR69","volume":"12","author":"CK Chan","year":"2020","unstructured":"Chan CK, Soldan A, Pettigrew C, Wang J, Albert M, Rosenberg PB. Depressive symptoms and CSF Alzheimer\u2019s disease biomarkers in relation to clinical symptom onset of mild cognitive impairment. Alzheimer\u2019s & dementia (Amsterdam, Netherlands). 2020;12:e12106.","journal-title":"Alzheimer\u2019s & dementia (Amsterdam, Netherlands)"},{"key":"2544_CR70","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1002\/alz.12785","volume":"19","author":"L Kleineidam","year":"2023","unstructured":"Kleineidam L, Wagner M, Guski J, Wolfsgruber S, Miebach L, Bickel H, et al. Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia. Alzheimer\u2019s & dementia\u202f: the journal of the Alzheimer\u2019s Association. 2023;19:2056\u201368.","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association"},{"key":"2544_CR71","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/gps.4489","volume":"32","author":"KD Harrington","year":"2017","unstructured":"Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, et al. Amyloid burden and incident depressive symptoms in cognitively normal older adults. Int J Geriatr Psychiatry. 2017;32:455\u201363.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2544_CR72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jad.2020.10.078","volume":"280","author":"ZT Wang","year":"2021","unstructured":"Wang ZT, Shen XN, Ma YH, Ou YN, Dong PQ, Tan PL, et al. Associations of the rate of change in geriatric depression scale with amyloid and cerebral glucose metabolism in cognitively normal older adults: a longitudinal study. J Affect Disord. 2021;280:77\u201384.","journal-title":"J Affect Disord"},{"key":"2544_CR73","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1176\/appi.ajp.2017.17040442","volume":"175","author":"NJ Donovan","year":"2018","unstructured":"Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, et al. Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry. 2018;175:530\u20137.","journal-title":"Am J Psychiatry"},{"key":"2544_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jad.2017.12.101","volume":"229","author":"S Perin","year":"2018","unstructured":"Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer\u2019s disease. J Affect Disord. 2018;229:269\u201374.","journal-title":"J Affect Disord"},{"key":"2544_CR75","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biopsych.2022.01.012","volume":"92","author":"M Johansson","year":"2022","unstructured":"Johansson M, Stomrud E, Johansson PM, Svenningsson A, Palmqvist S, Janelidze S, et al. Development of apathy, anxiety, and depression in cognitively unimpaired older adults: effects of Alzheimer\u2019s disease pathology and cognitive decline. Biol Psychiat. 2022;92:34\u201343.","journal-title":"Biol Psychiat"},{"key":"2544_CR76","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jagp.2025.04.207","volume":"33","author":"D Talmasov","year":"2025","unstructured":"Talmasov D, Johnson AS, Brown PJ, Provenzano FA, Lao PJ, Marder KS, et al. Depressive symptoms correlate with tau accumulation rates in amyloid positive adults. The American journal of geriatric psychiatry\u202f: official journal of the American Association for Geriatric Psychiatry. 2025;33:756\u201369.","journal-title":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry"},{"key":"2544_CR77","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.biopsych.2007.01.003","volume":"62","author":"X Sun","year":"2007","unstructured":"Sun X, Mwamburi DM, Bungay K, Prasad J, Yee J, Lin YM, et al. Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease. Biol Psychiat. 2007;62:1413\u20137.","journal-title":"Biol Psychiat"},{"key":"2544_CR78","first-page":"1621","volume":"10","author":"K Tsuruga","year":"2014","unstructured":"Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, et al. A positive correlation between serum amyloid \u03b2 levels and depressive symptoms among community-dwelling elderly individuals in Japan. Neuropsychiatr Dis Treat. 2014;10:1621\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2544_CR79","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/gps.1710","volume":"22","author":"WQ Qiu","year":"2007","unstructured":"Qiu WQ, Sun X, Selkoe DJ, Mwamburi DM, Huang T, Bhadela R, et al. Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly. Int J Geriatr Psychiatry. 2007;22:536\u201342.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2544_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.901403","volume":"13","author":"SE O'Bryant","year":"2022","unstructured":"O\u2019Bryant SE, Petersen M, Hall J, Johnson LA. Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans. Front Psych. 2022;13:901403.","journal-title":"Front Psych"},{"key":"2544_CR81","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/gps.4926","volume":"33","author":"MM Gonzales","year":"2018","unstructured":"Gonzales MM, Insel PS, Nelson C, Tosun D, Sch\u00f6ll M, Mattsson N, et al. Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment. Int J Geriatr Psychiatry. 2018;33:1305\u201311.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2544_CR82","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.pnpbp.2011.05.013","volume":"35","author":"YS Moon","year":"2011","unstructured":"Moon YS, Kang SH, No HJ, Won MH, Ki SB, Lee SK, et al. The correlation of plasma A\u03b242 levels, depressive symptoms, and cognitive function in the Korean elderly. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1603\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2544_CR83","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/acps.12352","volume":"131","author":"E Auning","year":"2015","unstructured":"Auning E, Selnes P, Grambaite R, \u0160altyt\u0117 Benth J, Haram A, L\u00f8vli Stav A, et al. Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment. Acta Psychiatr Scand. 2015;131:139\u201347.","journal-title":"Acta Psychiatr Scand"},{"key":"2544_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70530","volume":"21","author":"J Ikanga","year":"2025","unstructured":"Ikanga J, Patel SS, Schwinne M, Obenauf C, Gikelekele G, Epenge E, et al. Association between neuropsychiatric symptoms and neurodegeneration-related plasma biomarkers in older adults with and without clinical dementia in the Democratic Republic of the Congo. Alzheimer\u2019s & dementia\u202f: the journal of the Alzheimer\u2019s Association. 2025;21:e70530.","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association"},{"key":"2544_CR85","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad216","author":"M Zapater-Fajar\u00ed","year":"2024","unstructured":"Zapater-Fajar\u00ed M, Diaz-Galvan P, Cedres N, Rydberg Sterner T, Ryd\u00e9n L, Sacuiu S, et al. Biomarkers of Alzheimer\u2019s disease and cerebrovascular disease in relation to depressive symptomatology in individuals with subjective cognitive decline. J Gerontol A Biol Sci Med Sci. 2024. https:\/\/doi.org\/10.1093\/gerona\/glad216.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2025.11.005","volume":"158","author":"CS Dintica","year":"2026","unstructured":"Dintica CS, Johnson L, Petersen M, O\u2019Bryant S, Yaffe K. Depressive symptoms and plasma AT(N) biomarkers among cognitively healthy and mild cognitively impaired in a diverse cohort. Neurobiol Aging. 2026;158:11\u20137. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.11.005","journal-title":"Neurobiol Aging"},{"key":"2544_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71007","volume":"22","author":"JR Bacci","year":"2026","unstructured":"Bacci JR, Ryan J, Murray AM, Wu Z, Woods RL, Berk M, et al. The association of Alzheimer\u2019s disease and related dementias blood-based biomarkers with depressive symptoms. Alzheimer\u2019s & dementia\u202f: the journal of the Alzheimer\u2019s Association. 2026;22:e71007.","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association"},{"key":"2544_CR88","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S1041610217002368","volume":"30","author":"J Krell-Roesch","year":"2018","unstructured":"Krell-Roesch J, Lowe VJ, Neureiter J, Pink A, Roberts RO, Mielke MM, et al. Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging. Int Psychogeriatr. 2018;30:245\u201351.","journal-title":"Int Psychogeriatr"},{"key":"2544_CR89","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/0891988715606230","volume":"29","author":"JK Chung","year":"2016","unstructured":"Chung JK, Plitman E, Nakajima S, Chakravarty MM, Caravaggio F, Gerretsen P, et al. Cortical amyloid \u03b2 deposition and current depressive symptoms in Alzheimer disease and mild cognitive impairment. J Geriatr Psychiatry Neurol. 2016;29:149\u201359.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2544_CR90","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3233\/JAD-210232","volume":"82","author":"MM Gonzales","year":"2021","unstructured":"Gonzales MM, Samra J, O\u2019Donnell A, Mackin RS, Salinas J, Jacob ME, et al. Association of midlife depressive symptoms with regional amyloid-\u03b2 and tau in the Framingham Heart study. Journal of Alzheimer\u2019s disease\u202f: JAD. 2021;82:249\u201360.","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"2544_CR91","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/psyg.13016","volume":"23","author":"T Ozaki","year":"2023","unstructured":"Ozaki T, Hashimoto N, Udo N, Narita H, Nakagawa S, Kusumi I. Neurobiological correlation between phosphorylated tau and mood symptoms in memory clinic patients. Psychogeriatrics. 2023;23:954\u201362.","journal-title":"Psychogeriatrics"},{"key":"2544_CR92","volume":"4","author":"T Ozaki","year":"2025","unstructured":"Ozaki T, Hashimoto N, Narita H, Udo N, Mito S, Nakagawa S, et al. Association between higher cerebrospinal fluid levels of phosphorylated tau and reduced depressive symptoms in patients with cognitive decline. Psychiatry Clin Neurosci Rep. 2025;4:e70228.","journal-title":"Psychiatry Clin Neurosci Rep"},{"key":"2544_CR93","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/acps.12662","volume":"135","author":"J Buddeke","year":"2017","unstructured":"Buddeke J, Kooistra M, Zuithoff NP, Gerritsen L, Biessels GJ, van der Graaf Y, et al. Hippocampal volume and the course of depressive symptoms over eight years of follow-up. Acta Psychiatr Scand. 2017;135:78\u201386.","journal-title":"Acta Psychiatr Scand"},{"key":"2544_CR94","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/gps.4469","volume":"32","author":"WQ Qiu","year":"2017","unstructured":"Qiu WQ, Himali JJ, Wolf PA, DeCarli DC, Beiser A, Au R. Effects of white matter integrity and brain volumes on late life depression in the Framingham Heart Study. Int J Geriatr Psychiatry. 2017;32:214\u201321.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2544_CR95","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1017\/S003329172200112X","volume":"53","author":"F \u00d6zel","year":"2023","unstructured":"\u00d6zel F, Hilal S, de Feijter M, van der Velpen I, Direk N, Ikram MA, et al. Associations of neuroimaging markers with depressive symptoms over time in middle-aged and elderly persons. Psychol Med. 2023;53:4355\u201363.","journal-title":"Psychol Med"},{"key":"2544_CR96","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jad.2020.05.097","volume":"274","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Wei F, Shen XN, Ma YH, Chen KL, Dong Q, et al. Associations of subsyndromal symptomatic depression with cognitive decline and brain atrophy in elderly individuals without dementia: a longitudinal study. J Affect Disord. 2020;274:262\u20138.","journal-title":"J Affect Disord"},{"key":"2544_CR97","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/13607863.2018.1432030","volume":"23","author":"SM Szymkowicz","year":"2019","unstructured":"Szymkowicz SM, Woods AJ, Dotson VM, Porges EC, Nissim NR, O\u2019Shea A, et al. Associations between subclinical depressive symptoms and reduced brain volume in middle-aged to older adults. Aging Ment Health. 2019;23:819\u201330.","journal-title":"Aging Ment Health"},{"key":"2544_CR98","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biopsych.2011.04.014","volume":"70","author":"T den Heijer","year":"2011","unstructured":"den Heijer T, Tiemeier H, Luijendijk HJ, van der Lijn F, Koudstaal PJ, Hofman A, et al. A study of the bidirectional association between hippocampal volume on magnetic resonance imaging and depression in the elderly. Biol Psychiat. 2011;70:191\u20137.","journal-title":"Biol Psychiat"},{"key":"2544_CR99","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2021.09.025","volume":"111","author":"L Gerritsen","year":"2022","unstructured":"Gerritsen L, Sigurdsson S, Jonsson PV, Gudnason V, Launer LJ, Geerlings MI. Depressive symptom profiles predict dementia onset and brain pathology in older persons. The AGES-Reykjavik study. Neurobiol Aging. 2022;111:14\u201323.","journal-title":"Neurobiol Aging"},{"key":"2544_CR100","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1139\/jpn.0948","volume":"34","author":"VM Dotson","year":"2009","unstructured":"Dotson VM, Davatzikos C, Kraut MA, Resnick SM. Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study. Journal of psychiatry & neuroscience\u202f: JPN. 2009;34:367\u201375.","journal-title":"Journal of psychiatry & neuroscience : JPN"},{"key":"2544_CR101","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.rceng.2024.07.002","volume":"224","author":"Q Xu","year":"2024","unstructured":"Xu Q, Wang J, Li H, Gao Y. Association between serum neurofilament light chains (sNfL) and neurologic disorders in a representative sample of US adults: a cross-sectional study. Revista Cl\u00ednica Espa\u00f1ola (English Edition). 2024;224:510\u201321.","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"key":"2544_CR102","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jad.2024.07.146","volume":"363","author":"M Guo","year":"2024","unstructured":"Guo M, Zhu C. Serum neurofilament light chain, markers of systemic inflammation and clinically relevant depressive symptoms in US adults. J Affect Disord. 2024;363:572\u20138.","journal-title":"J Affect Disord"},{"key":"2544_CR103","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jad.2024.05.165","volume":"360","author":"Y Xu","year":"2024","unstructured":"Xu Y, Chen A, Chen R, Zheng W. Association between depressive symptoms and cognitive function in the older population, and the mediating role of neurofilament light chain: evidence from NHANES 2013-2014. J Affect Disord. 2024;360:221\u20138.","journal-title":"J Affect Disord"},{"key":"2544_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-05964-0","volume":"24","author":"Y Song","year":"2024","unstructured":"Song Y, Jiao H, Weng Q, Liu H, Yi L. Serum neurofilament light chain levels are associated with depression among US adults: a cross-sectional analysis among US adults, 2013-2014. BMC Psychiatry. 2024;24:527.","journal-title":"BMC Psychiatry"},{"key":"2544_CR105","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jad.2024.08.130","volume":"366","author":"X Liu","year":"2024","unstructured":"Liu X, Chen X, Chen J. Relationship between serum neurofilament light chain protein and depression: a nationwide survey and Mendelian randomization study. J Affect Disord. 2024;366:162\u201371.","journal-title":"J Affect Disord"},{"key":"2544_CR106","volume":"11","author":"F Bellelli","year":"2025","unstructured":"Bellelli F, Raffin J, Angioni D, Romana J, Soto M, Delrieu J, et al. The relationship between neurofilament light chain and depressive symptoms according to cognitive status. Alzheimer\u2019s & dementia (New York, N Y). 2025;11:e70048.","journal-title":"Alzheimer\u2019s & dementia (New York, N Y)"},{"key":"2544_CR107","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jad.2024.09.018","volume":"367","author":"C Jing","year":"2024","unstructured":"Jing C, Kong M, Ng KP, Xu L, Ma G, Ba M. Hippocampal volume maximally modulates the relationship between subsyndromal symptomatic depression and cognitive impairment in non-demented older adults. J Affect Disord. 2024;367:640\u20136.","journal-title":"J Affect Disord"},{"key":"2544_CR108","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/npp.2013.271","volume":"39","author":"ES Brown","year":"2014","unstructured":"Brown ES, Hughes CW, McColl R, Peshock R, King KS, Rush AJ. Association of depressive symptoms with hippocampal volume in 1936 adults. Neuropsychopharmacology\u202f: official publication of the American College of Neuropsychopharmacology. 2014;39:770\u20139.","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"2544_CR109","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/hipo.22185","volume":"23","author":"A Ezzati","year":"2013","unstructured":"Ezzati A, Zimmerman ME, Katz MJ, Lipton RB. Hippocampal correlates of depression in healthy elderly adults. Hippocampus. 2013;23:1137\u201342.","journal-title":"Hippocampus"},{"key":"2544_CR110","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3233\/JAD-170041","volume":"58","author":"A Pink","year":"2017","unstructured":"Pink A, Przybelski SA, Krell-Roesch J, Stokin GB, Roberts RO, Mielke MM, et al. Cortical thickness and depressive symptoms in cognitively normal individuals: the Mayo Clinic study of aging. J Alzheimers Dis. 2017;58:1273\u201381.","journal-title":"J Alzheimers Dis"},{"key":"2544_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119998","volume":"391","author":"I Vom Hofe","year":"2025","unstructured":"Vom Hofe I, Luik AI, Vernooij MW, van den Berg E, Wolters FJ. Subcortical grey matter structures in relation to symptoms of depression and anxiety on the spectrum from cognitively healthy to dementia. J Affect Disord. 2025;391:119998.","journal-title":"J Affect Disord"},{"key":"2544_CR112","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3233\/JAD-160326","volume":"53","author":"J Krell-Roesch","year":"2016","unstructured":"Krell-Roesch J, Ruider H, Lowe VJ, Stokin GB, Pink A, Roberts RO, et al. FDG-PET and neuropsychiatric symptoms among cognitively normal elderly persons: the Mayo Clinic study of aging. J Alzheimers Dis. 2016;53:1609\u201316.","journal-title":"J Alzheimers Dis"},{"key":"2544_CR113","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.18632\/aging.101971","volume":"11","author":"W Xu","year":"2019","unstructured":"Xu W, Zhang C, Li JQ, Tan CC, Cao XP, Tan L, et al. Age-related hearing loss accelerates cerebrospinal fluid tau levels and brain atrophy: a longitudinal study. Aging. 2019;11:3156\u201369.","journal-title":"Aging"},{"key":"2544_CR114","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2022.08.008","volume":"120","author":"AJ Paulsen","year":"2022","unstructured":"Paulsen AJ, Schubert CR, Pinto AA, Chappell RJ, Chen Y, Cruickshanks KJ, et al. Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer\u2019s disease in midlife. Neurobiol Aging. 2022;120:177\u201388.","journal-title":"Neurobiol Aging"},{"key":"2544_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30423","volume":"10","author":"M Lad","year":"2024","unstructured":"Lad M, Taylor JP, Griffiths TD. Subjective hearing loss is not associated with an increased risk of Alzheimer\u2019s disease dementia. Heliyon. 2024;10:e30423.","journal-title":"Heliyon"},{"key":"2544_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104336","volume":"86","author":"HF Wang","year":"2022","unstructured":"Wang HF, Zhang W, Rolls ET, Li Y, Wang L, Ma YH, et al. Hearing impairment is associated with cognitive decline, brain atrophy and tau pathology. EBioMedicine. 2022;86:104336.","journal-title":"EBioMedicine"},{"key":"2544_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.911028","volume":"14","author":"WJ Zhang","year":"2022","unstructured":"Zhang WJ, Li DN, Lian TH, Guo P, Zhang YN, Li JH, et al. Clinical features and potential mechanisms relating neuropathological biomarkers and blood-brain barrier in patients with Alzheimer\u2019s disease and hearing loss. Front Aging Neurosci. 2022;14:911028.","journal-title":"Front Aging Neurosci"},{"key":"2544_CR118","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s10072-023-07143-7","volume":"45","author":"F Mart\u00ednez-Dubarbie","year":"2024","unstructured":"Mart\u00ednez-Dubarbie F, Lobo D, Roll\u00e1n-Mart\u00ednez-Herrera M, L\u00f3pez-Garc\u00eda S, Lage C, Fern\u00e1ndez-Matarrubia M, et al. Age-related hearing loss is not linked to cerebrospinal fluid levels of \u03b2-amyloid or p-tau181. Neurol Sci. 2024;45:1471\u201380.","journal-title":"Neurol Sci"},{"key":"2544_CR119","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1097\/MAO.0000000000003454","volume":"43","author":"AL Irace","year":"2022","unstructured":"Irace AL, Rippon BQ, Brickman AM, Luchsinger JA, Golub JS. The laterality of early age-related hearing loss and brain \u03b2-amyloid. Otol Neurotol. 2022;43:e382\u201390.","journal-title":"Otol Neurotol"},{"key":"2544_CR120","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/lary.28859","volume":"131","author":"JS Golub","year":"2021","unstructured":"Golub JS, Sharma RK, Rippon BQ, Brickman AM, Luchsinger JA. The association between early age-related hearing loss and brain \u03b2-amyloid. Laryngoscope. 2021;131:633\u20138.","journal-title":"Laryngoscope"},{"key":"2544_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14466-6","volume":"12","author":"M Zheng","year":"2022","unstructured":"Zheng M, Yan J, Hao W, Ren Y, Zhou M, Wang Y, et al. Worsening hearing was associated with higher \u03b2-amyloid and tau burden in age-related hearing loss. Sci Rep. 2022;12:10493.","journal-title":"Sci Rep"},{"key":"2544_CR122","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JAD-215121","volume":"85","author":"JZ Sarant","year":"2022","unstructured":"Sarant JZ, Harris DC, Busby PA, Fowler C, Fripp J, Masters CL, et al. No influence of age-related hearing loss on brain amyloid-\u03b2. Journal of Alzheimer\u2019s disease\u202f: JAD. 2022;85:359\u201367.","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"2544_CR123","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/jnnp-2019-321897","volume":"91","author":"T Parker","year":"2020","unstructured":"Parker T, Cash DM, Lane C, Lu K, Malone IB, Nicholas JM, et al. Pure tone audiometry and cerebral pathology in healthy older adults. J Neurol Neurosurg Psychiatry. 2020;91:172\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2544_CR124","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1093\/gerona\/glad159","volume":"78","author":"JA Deal","year":"2023","unstructured":"Deal JA, Jiang K, Rawlings A, Sharrett AR, Reed NS, Knopman D, et al. Hearing, \u03b2-amyloid deposition and cognitive test performance in Black and White older adults: the ARIC-PET study. J Gerontol A Biol Sci Med Sci. 2023;78:2105\u201310.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2544_CR125","volume":"15","author":"L Yesantharao","year":"2023","unstructured":"Yesantharao L, Cai Y, Schrack JA, Gross AL, Wang H, Bilgel M, et al. Sensory impairment and beta-amyloid deposition in the Baltimore longitudinal study of aging. Alzheimer\u2019s & dementia (Amsterdam, Netherlands). 2023;15:e12407.","journal-title":"Alzheimer\u2019s & dementia (Amsterdam, Netherlands)"},{"key":"2544_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030672","author":"G Alberti","year":"2025","unstructured":"Alberti G, Portelli D, Polito F, Graceffa A, Licitri L, Loteta S, et al. Blood neurofilament light chain and phospho-Tau 181 in subjects with mild cognitive impairment due to age-related hearing loss. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14030672.","journal-title":"J Clin Med"},{"key":"2544_CR127","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/ohn.583","volume":"170","author":"KR Khandalavala","year":"2024","unstructured":"Khandalavala KR, Marinelli JP, Lohse CM, Przybelski SA, Petersen RC, Vassilaki M, et al. Neuroimaging characteristics of hearing loss in the Mayo Clinic study of aging. Otolaryngol Head Neck Surg. 2024;170:886\u201395.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2544_CR128","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/jnnp-2023-333101","volume":"95","author":"TD Parker","year":"2024","unstructured":"Parker TD, Hardy C, Keuss S, Coath W, Cash DM, Lu K, et al. Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change. J Neurol Neurosurg Psychiatry. 2024;95:829\u201332.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2544_CR129","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuroimage.2013.12.059","volume":"90","author":"FR Lin","year":"2014","unstructured":"Lin FR, Ferrucci L, An Y, Goh JO, Doshi J, Metter EJ, et al. Association of hearing impairment with brain volume changes in older adults. Neuroimage. 2014;90:84\u201392.","journal-title":"Neuroimage"},{"key":"2544_CR130","doi-asserted-by":"publisher","first-page":"e2539209","DOI":"10.1001\/jamanetworkopen.2025.39209","volume":"8","author":"FB Kolo","year":"2025","unstructured":"Kolo FB, Lu S, Beiser AS, Francis L, Melo van Lent D, Gireud-Goss M, et al. Hearing loss, brain structure, cognition, and dementia risk in the Framingham Heart study. JAMA Netw Open. 2025;8:e2539209.","journal-title":"JAMA Netw Open"},{"key":"2544_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3374","volume":"14","author":"JH Han","year":"2024","unstructured":"Han JH, Lee S, Bae SH, Yun M, Ye BS, Jung J. Distinct changes in brain metabolism in patients with dementia and hearing loss. Brain Behav. 2024;14:e3374.","journal-title":"Brain Behav"},{"key":"2544_CR132","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/ggi.15052","volume":"25","author":"R Sakurai","year":"2025","unstructured":"Sakurai R, Kim Y, Nishinakagawa M, Hinakura K, Fujiwara Y, Ishii K. Neural correlates of age-related hearing loss: an MRI and FDG-PET study. Geriatr Gerontol Int. 2025;25:300\u20136.","journal-title":"Geriatr Gerontol Int"},{"key":"2544_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00002","volume":"9","author":"SC Rigters","year":"2017","unstructured":"Rigters SC, Bos D, Metselaar M, Roshchupkin GV, Baatenburg de Jong RJ, Ikram MA, et al. Hearing impairment is associated with smaller brain volume in aging. Front Aging Neurosci. 2017;9:2.","journal-title":"Front Aging Neurosci"},{"key":"2544_CR134","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2023.634","volume":"10","author":"X Chen","year":"2024","unstructured":"Chen X, Hu K, Song H, Yin L, Kaijser M, Gurholt TP, et al. Depression, anxiety and brain volume after hearing loss and tinnitus: cohort study in the UK Biobank. BJPsych Open. 2024;10:e37.","journal-title":"BJPsych Open"},{"key":"2544_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00319","volume":"10","author":"Y Uchida","year":"2018","unstructured":"Uchida Y, Nishita Y, Kato T, Iwata K, Sugiura S, Suzuki H, et al. Smaller hippocampal volume and degraded peripheral hearing among Japanese community dwellers. Front Aging Neurosci. 2018;10:319.","journal-title":"Front Aging Neurosci"},{"key":"2544_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbas.2021.100018","volume":"1","author":"N Giroud","year":"2021","unstructured":"Giroud N, Pichora-Fuller MK, Mick P, Wittich W, Al-Yawer F, Rehan S, et al. Hearing loss is associated with gray matter differences in older adults at risk for and with Alzheimer\u2019s disease. Aging Brain. 2021;1:100018.","journal-title":"Aging Brain"},{"key":"2544_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1602383","volume":"16","author":"YJ Lee","year":"2025","unstructured":"Lee YJ, Lee EJ, Suh CH, Youn HJ, Chae J, Park K, et al. Brain volumetric analysis of elderly patients based on hearing levels quantified using FreeSurfer. Front Neurol. 2025;16:1602383.","journal-title":"Front Neurol"},{"key":"2544_CR138","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3233\/JAD-240522","volume":"101","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhao S, Feng J, Wang S, Song L, Han Q, et al. High-frequency hearing loss, hippocampal volume, and motoric cognitive risk syndrome in older adults in China: a population-based study. J Alzheimers Dis. 2024;101:487\u201398.","journal-title":"J Alzheimers Dis"},{"key":"2544_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78571-0","volume":"10","author":"EA Koops","year":"2020","unstructured":"Koops EA, de Kleine E, van Dijk P. Gray matter declines with age and hearing loss, but is partially maintained in tinnitus. Sci Rep. 2020;10:21801.","journal-title":"Sci Rep"},{"key":"2544_CR140","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1176\/ajp.2006.163.12.2164","volume":"163","author":"JG Csernansky","year":"2006","unstructured":"Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.\u00a0Am J Psychiatry. 2006;163(12):2164\u20139.\u00a0https:\/\/doi.org\/10.1176\/ajp.2006.163.12.2164","journal-title":"Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia"},{"key":"2544_CR141","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1515\/revneuro-2014-0035","volume":"25","author":"A Machado","year":"2014","unstructured":"Machado A, Herrera AJ, de Pablos RM, Espinosa-Oliva AM, Sarmiento M, Ayala A, et al. Chronic stress as a risk factor for Alzheimer\u2019s disease. Rev Neurosci. 2014;25(6):785-804.\u00a0https:\/\/doi.org\/10.1515\/revneuro-2014-0035","journal-title":"Chronic stress as a risk factor for Alzheimer\u2019s disease"},{"key":"2544_CR142","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing commission. Lancet. 2024;404:572\u2013628.","journal-title":"Lancet"},{"key":"2544_CR143","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s43587-023-00522-x","volume":"3","author":"WH Lu","year":"2023","unstructured":"Lu WH, Rolland Y, Guyonnet S, de Souto Barreto P, Vellas B. Reference centiles for intrinsic capacity throughout adulthood and their association with clinical outcomes: a cross-sectional analysis from the INSPIRE-T cohort. Nat Aging. 2023;3:1521\u20138.","journal-title":"Nat Aging"},{"key":"2544_CR144","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s43587-025-00861-x","volume":"5","author":"P de Souto Barreto","year":"2025","unstructured":"de Souto Barreto P, Lu WH, Tavassoli N, Nourhash\u00e9mi F, Gorga Bandeira de Mello R, Ferriolli E, et al. Reference centiles for intrinsic capacity to monitor clinical health outcomes in real-world primary care cohorts. Nat Aging. 2025;5:1217\u201331.","journal-title":"Nat Aging"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02544-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:02:01Z","timestamp":1789783321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02544-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":144,"alternative-id":["2544"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02544-w","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}